Benitec Biopharma Inc. (BNTC) Current Reports & Earnings Releases
Upcoming
- 2026-09-21 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-05-29 | 8-K | Officer / Director Changes | SEC |
| 2026-05-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-02-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-12-02 | 8-K | Shareholder Vote Results | SEC |
| 2025-11-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-11-07 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2025-11-03 | 8-K | Officer / Director Changes, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-09-22 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-09-12 | 8-K | Non-Reliance on Financials | SEC |
| 2025-07-09 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-05-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-28 | 8-K | Other Events | SEC |
| 2025-03-27 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-03-26 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2025-03-20 | 8-K | Other Events | SEC |
| 2025-03-19 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-02-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-12-13 | 8-K | Officer / Director Changes | SEC |
| 2024-12-10 | 8-K | Item 3.03, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2024-12-06 | 8-K | Shareholder Vote Results | SEC |
| 2024-11-14 | 8-K | Officer / Director Changes | SEC |
| 2024-11-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-10-15 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-10-11 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-10-08 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-09-26 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-09-05 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-07-15 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-07-01 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-05-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-04-19 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-04-18 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-03-08 | 8-K | Officer / Director Changes | SEC |
| 2024-02-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.